Iron Level Re-Testing After Monofer Infusion

Optimal Timing for Re-Testing

Iron parameters should not be evaluated within 4 weeks of intravenous iron administration, as serum levels of ferritin increase markedly following administration and cannot be utilized as a reliable marker of iron status during this period 1
Following iron replacement, iron status should be re-evaluated in 3 months, with further iron repletion provided as needed 2, 3
Laboratory evaluation following IV iron should include complete blood count (CBC) and iron parameters (ferritin, percent transferrin saturation) 4 to 8 weeks after the last infusion 1, 4

Ferritin levels increase significantly after IV iron administration, creating falsely elevated readings that do not accurately reflect true iron stores if measured too soon 2, 5
The 3-month interval allows sufficient time for the body to process and distribute the administered iron, providing a more accurate assessment of the patient's iron status 3
Hemoglobin concentrations typically increase within 1-2 weeks of treatment and should increase by 1-2 g/dL within 4-8 weeks of therapy 1

Key parameters to measure at follow-up include hemoglobin, hematocrit, ferritin, and transferrin saturation (TSAT) 2, 1
TSAT is calculated by dividing the serum iron concentration by the total iron-binding capacity and multiplying by 100 2
For accurate assessment of iron parameters after intravenous infusion of larger doses (≥1000 mg), an interval of at least 2 weeks should occur, though 3 months is optimal 6

If there is no response or hemoglobin levels decrease after treatment, further investigation for other underlying causes should be considered, particularly occult blood loss 3, 5
After correction of iron deficiency, consider re-evaluation of iron parameters 1-2 times per year as part of routine follow-up 3
Iron status should be re-evaluated if patients remain symptomatic despite receiving optimal background medications, or if hemoglobin levels decrease 5

If MRI imaging is needed, the required time interval between the last IV iron infusion and MRI for Monofer (iron isomaltoside/ferric derisomaltose) is 1 month to avoid magnetic interference 7
This differs from other iron preparations such as iron sucrose and ferric carboxymaltose (1 week), high-molecular-weight iron dextran (3 months), or ferumoxytol (6 months) 7

Following attainment of target hemoglobin/hematocrit levels, TSAT and serum ferritin should be determined at least once every 3 months in patients on regular iron therapy 6
For patients with chronic conditions requiring ongoing iron monitoring, consider evaluating iron status as part of routine practice 1-2 times per year 2, 3

For larger IV iron doses (≥1000 mg), the National Kidney Foundation recommends waiting at least 2 weeks before checking iron parameters, though 4-8 weeks is optimal for accurate assessment 8
For smaller IV iron doses (100-125 mg per week), iron parameters can be measured without interrupting therapy, as suggested by the National Kidney Foundation 8, 9
Key parameters to measure at follow-up include hemoglobin, hematocrit, ferritin, and transferrin saturation (TSAT), according to the National Kidney Foundation 8, 9

In patients with chronic kidney disease, the National Kidney Foundation recommends target ferritin levels of at least 100 ng/mL 8
The National Kidney Foundation also recommends a target TSAT of at least 20% in patients with chronic kidney disease 8
Patients are unlikely to respond with further increases in hemoglobin if TSAT exceeds 50% or ferritin exceeds 800 ng/mL, as noted by the National Kidney Foundation 8
For patients on regular IV iron therapy, iron status should be monitored at least once every 3 months after target hemoglobin levels are reached, according to the National Kidney Foundation 8, 9
In patients with chronic kidney disease not on erythropoietin therapy with low iron parameters, the National Kidney Foundation suggests monitoring iron status every 3-6 months 8